250 related articles for article (PubMed ID: 20947021)
41. Helix12-Stabilization Antagonist of Vitamin D Receptor.
Kato A; Itoh T; Anami Y; Egawa D; Yamamoto K
Bioconjug Chem; 2016 Jul; 27(7):1750-61. PubMed ID: 27294600
[TBL] [Abstract][Full Text] [Related]
42. HDX reveals unique fragment ligands for the vitamin D receptor.
Carson MW; Zhang J; Chalmers MJ; Bocchinfuso WP; Holifield KD; Masquelin T; Stites RE; Stayrook KR; Griffin PR; Dodge JA
Bioorg Med Chem Lett; 2014 Aug; 24(15):3459-63. PubMed ID: 24974344
[TBL] [Abstract][Full Text] [Related]
43. Regulation of ligand-induced heterodimerization and coactivator interaction by the activation function-2 domain of the vitamin D receptor.
Liu YY; Nguyen C; Peleg S
Mol Endocrinol; 2000 Nov; 14(11):1776-87. PubMed ID: 11075811
[TBL] [Abstract][Full Text] [Related]
44. Selective effects of ligands on vitamin D3 receptor- and retinoid X receptor-mediated gene activation in vivo.
Lemon BD; Freedman LP
Mol Cell Biol; 1996 Mar; 16(3):1006-16. PubMed ID: 8622645
[TBL] [Abstract][Full Text] [Related]
45. Conformational analysis of g protein-coupled receptor signaling by hydrogen/deuterium exchange mass spectrometry.
Li S; Lee SY; Chung KY
Methods Enzymol; 2015; 557():261-78. PubMed ID: 25950969
[TBL] [Abstract][Full Text] [Related]
46. Distinct retinoid X receptor activation function-2 residues mediate transactivation in homodimeric and vitamin D receptor heterodimeric contexts.
Thompson PD; Remus LS; Hsieh JC; Jurutka PW; Whitfield GK; Galligan MA; Encinas Dominguez C; Haussler CA; Haussler MR
J Mol Endocrinol; 2001 Oct; 27(2):211-27. PubMed ID: 11564604
[TBL] [Abstract][Full Text] [Related]
47. Evidence for 1,25-dihydroxyvitamin D3-independent transactivation by the vitamin D receptor: uncoupling the receptor and ligand in keratinocytes.
Ellison TI; Eckert RL; MacDonald PN
J Biol Chem; 2007 Apr; 282(15):10953-62. PubMed ID: 17310066
[TBL] [Abstract][Full Text] [Related]
48. Characterization of the interaction between retinoic acid receptor/retinoid X receptor (RAR/RXR) heterodimers and transcriptional coactivators through structural and fluorescence anisotropy studies.
Pogenberg V; Guichou JF; Vivat-Hannah V; Kammerer S; Pérez E; Germain P; de Lera AR; Gronemeyer H; Royer CA; Bourguet W
J Biol Chem; 2005 Jan; 280(2):1625-33. PubMed ID: 15528208
[TBL] [Abstract][Full Text] [Related]
49. Examination of the potential functional role of conserved cysteine residues in the hormone binding domain of the human 1,25-dihydroxyvitamin D3 receptor.
Nakajima S; Hsieh JC; Jurutka P; Galligan MA; Haussler CA; Whitfield GK; Haussler MR
J Biol Chem; 1996 Mar; 271(9):5143-9. PubMed ID: 8617794
[TBL] [Abstract][Full Text] [Related]
50. Conformational changes of the glucocorticoid receptor ligand binding domain induced by ligand and cofactor binding, and the location of cofactor binding sites determined by hydrogen/deuterium exchange mass spectrometry.
Frego L; Davidson W
Protein Sci; 2006 Apr; 15(4):722-30. PubMed ID: 16600964
[TBL] [Abstract][Full Text] [Related]
51. Relationship between Structure and Conformational Change of the Vitamin D Receptor Ligand Binding Domain in 1α,25-Dihydroxyvitamin D3 Signaling.
Wan LY; Zhang YQ; Chen MD; Du YQ; Liu CB; Wu JF
Molecules; 2015 Nov; 20(11):20473-86. PubMed ID: 26593892
[TBL] [Abstract][Full Text] [Related]
52. The autonomous transactivation domain in helix H3 of the vitamin D receptor is required for transactivation and coactivator interaction.
Kraichely DM; Collins JJ; DeLisle RK; MacDonald PN
J Biol Chem; 1999 May; 274(20):14352-8. PubMed ID: 10318858
[TBL] [Abstract][Full Text] [Related]
53. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
54. Structural variants of the vitamin D analogue EB1089 reduce its ligand sensitivity and promoter selectivity.
Quack M; Clarin A; Binderup E; Björkling F; Hansen CM; Carlberg C
J Cell Biochem; 1998 Dec; 71(3):340-50. PubMed ID: 9831071
[TBL] [Abstract][Full Text] [Related]
55. Molecular structure of the rat vitamin D receptor ligand binding domain complexed with 2-carbon-substituted vitamin D3 hormone analogues and a LXXLL-containing coactivator peptide.
Vanhooke JL; Benning MM; Bauer CB; Pike JW; DeLuca HF
Biochemistry; 2004 Apr; 43(14):4101-10. PubMed ID: 15065852
[TBL] [Abstract][Full Text] [Related]
56. Genomic actions of 1,25-dihydroxyvitamin D3.
Whitfield GK; Hsieh JC; Jurutka PW; Selznick SH; Haussler CA; MacDonald PN; Haussler MR
J Nutr; 1995 Jun; 125(6 Suppl):1690S-1694S. PubMed ID: 7782928
[TBL] [Abstract][Full Text] [Related]
57. Development of vitamin D analogs modulating the pocket structure of vitamin D receptor.
Yamamoto K; Anami Y; Itoh T
Curr Top Med Chem; 2014; 14(21):2378-87. PubMed ID: 25537068
[TBL] [Abstract][Full Text] [Related]
58. Response element and coactivator-mediated conformational change of the vitamin D(3) receptor permits sensitive interaction with agonists.
Herdick M; Bury Y; Quack M; Uskokovic MR; Polly P; Carlberg C
Mol Pharmacol; 2000 Jun; 57(6):1206-17. PubMed ID: 10825392
[TBL] [Abstract][Full Text] [Related]
59. Molecular and functional comparison of 1,25-dihydroxyvitamin D(3) and the novel vitamin D receptor ligand, lithocholic acid, in activating transcription of cytochrome P450 3A4.
Jurutka PW; Thompson PD; Whitfield GK; Eichhorst KR; Hall N; Dominguez CE; Hsieh JC; Haussler CA; Haussler MR
J Cell Biochem; 2005 Apr; 94(5):917-43. PubMed ID: 15578590
[TBL] [Abstract][Full Text] [Related]
60. Differential regulation of heterodimerization by 1alpha,25-dihydroxyvitamin D(3) and its 20-epi analog.
Liu YY; Nguyen C; Ali Gardezi SA; Schnirer I; Peleg S
Steroids; 2001; 66(3-5):203-12. PubMed ID: 11179727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
